Scientists have cracked how bacteria build cancer-fighting compounds, a breakthrough that could speed up new treatments. The ...

A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, ...

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Brain cancer breakthrough as new study finds cell therapy could target deadly glioblastoma - Patients diagnosed with ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Researchers at McMaster University have developed a new cancer immunotherapy strategy that can simultaneously attack deadly ...

She specifically discusses the available treatment options in frontline EGFR mutation–positive advanced non–small cell lung cancer and what particular clinical and lifestyle benefits are provided by ...

Researchers at UCLA found that creatine not only enhances cancer-fighting killer T cells but also strengthens dendritic cells, which activate and direct T cells to attack tumors.

Misako Nagasaka, MD, PhD, discusses optimizing patient management when administering frontline SC amivantamab plus lazertinib in patients with EGFR-mutated advanced non–small cell lung cancer. She ...